Cell host & microbe

Gut microbes may affect stroke severity through a compound called trimethylamine N-oxide

Updated

Abstract

Fecal microbial transplantation from low- versus high-TMAO-producing human subjects into germ-free mice shows that both TMAO generation and stroke severity are transmissible traits.

  • Circulating levels of the metabolite trimethylamine-N-oxide (TMAO) are associated with increased stroke incident risk.
  • Gut microbes influence stroke outcomes through dietary choline and the generation of TMAO.
  • Transplantation of gut microbiota exhibits a direct impact on cerebral infarct size and functional impairment after stroke.
  • The microbial cutC gene is identified as a key contributor to the transformation of choline to TMAO, affecting stroke severity.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of interests S.L.H. reports being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics, being a paid consultant for Procter & Gamble, having received research funds from Procter & Gamble and Roche Diagnostics, and being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland HeartLab, a subsidiary of Quest Diagnostics, and Procter & Gamble. The other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free